MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Falling oil prices and easing inflation may set up the Fed for a larger rate cut ahead, a move that could revive the housing market and support the S&P 500's longer-term uptrend.
DraftKings (NASDAQ:DKNG) CEO and Chairman Jason Robins said the company is seeing strong early-season engagement across its core sportsbook business and its newer prediction markets offering, while maintaining its expectation of about $1 billion in adjusted EBITDA for 2026.
Speaking with Wells Farg
IonQ and partners at Oak Ridge National Laboratory and NVIDIA used generative AI to speed quantum circuit design, cutting runtime dramatically, though commercial impact remains unclear.
CEO Hock Tan defended Broadcom's $350 billion AI chip outlook amid Anthropic's calls to slow frontier AI development, citing the company's inference-focused customer relationships.
AutoZone (NYSE:AZO) reported fiscal 2026 fourth-quarter sales growth of 5.6% to $6.6 billion, while diluted earnings per share rose 15.1% to $56.05. The company said its results included a $96 million benefit from tariff refunds and a $15 million non-cash LIFO charge.
For the full fiscal year, sale
Celldex Therapeutics (NASDAQ:CLDX) reported positive top-line results from its two Phase III EMBARQ-CSU studies of barzolvolimab in adults with chronic spontaneous urticaria, or CSU, who remained symptomatic despite H1 antihistamine treatment. The company said both evaluated dose regimens met the pr
ACG Acquisition (LON:ACG) said its updated technical report for the Gediktepe mining operation in Türkiye increased the project’s estimated net present value and lifted expected copper-equivalent production over the next five years.
Artem, the company’s chair and chief executive officer, said Gedik
Microsoft raised its quarterly dividend 7.69% to 98 cents per share, marking 23 straight years of increases even as AI-related capital spending pressures free cash flow.
Analog Devices (NASDAQ:ADI) Chief Financial Officer Rich Puccio said the company expects demand strength across its portfolio to support double-digit growth into fiscal 2027, citing broad-based recovery in industrial markets alongside continued momentum in data centers, aerospace and defense, and au
A multi-state settlement cleared the main legal hurdle to Paramount Skydance's $111 billion Warner Bros. Discovery deal, requiring production and labor concessions as WBD and PSKY shares reacted sharply.
Apple's market cap has climbed to roughly $4.95 trillion on strong iPhone demand, closing in on NVIDIA's approximately $5.48 trillion, as investors watch whether Apple can overtake the AI chipmaker again.
MillerKnoll (NASDAQ:MLKN) reported first-quarter fiscal 2027 sales and orders that reflected uneven demand across its businesses, as strong International Contract and Global Retail order trends were offset by softer-than-expected North America Contract activity.
For the quarter ended Aug. 29, 2026,
Viking Therapeutics (NASDAQ:VKTX) reported top-line results from a maintenance dosing study of VK2735, its dual GLP-1/GIP receptor agonist candidate for obesity, showing that participants retained much of their initial weight loss after transitioning from weekly treatment to every-other-week or mont
Oxford Biomedica (LON:OXB) reported higher first-half revenue and improved operating EBITDA as manufacturing activity increased, while management reiterated its full-year 2026 revenue guidance and longer-term growth targets.
Revenue for the six months ended in 2026 rose 10% at constant currency to
Meta Platforms unveiled Petal, a petabit-scale subsea cable linking the U.S. and France, boosting demand for optical infrastructure suppliers like Corning amid AI-driven data center buildouts.
Goldman Sachs cut its Tesla delivery estimates for the third and fourth quarters, but shares held near recent highs as investors focus on Tesla's robotaxi and AI ambitions instead.
Encore Capital Group's stock has more than doubled as record debt collections and rising charge-offs drove Q2 earnings beats, prompting raised full-year guidance and bullish analyst ratings.
Cybin (NASDAQ:HELP), doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider resolutions related to the company’s auditor, board size, corporate name and director elections.
Eric So, the company’s co-founder and executiv
Here Group reported fourth-quarter revenue of CNY127.7 million for fiscal 2026, an increase of 94.1% from a year earlier, as sales of existing and newly launched pop-toy intellectual property products rose. Full-year revenue reached CNY596.8 million, according to Founder, Chairman and Chief Executiv
Texas Roadhouse posted record sales and revenue growth in Q2, but rising beef costs squeezed margins, sending shares down 19% despite a Moderate Buy analyst consensus.
Pfizer (NYSE:PFE) has rebuilt its commercial model around newer and acquired products while reducing exposure to its COVID-19 franchise, according to Alexandre de Germay, the company’s chief international commercial officer and executive vice president.
Speaking with Chris Schott at a company event
Nucor and Steel Dynamics shares are pulling back after Q3 guidance missed estimates, but higher steel prices, strong backlogs, and wide margins support analysts' bullish price targets.
Amazon struck a deal worth up to $8 billion with Generac for backup generators to power its AI data centers, underscoring how electricity supply has become a critical bottleneck in its AI buildout.
Sanofi (NASDAQ:SNY) is reviewing its late-stage pipeline, broadening its business-development lens and working to rebuild early research output under new leadership, Chief Scientific Officer and Global Head of Research Mike Quigley said at a Bank of America event.
Quigley said Chief Executive Offic
PureTech Health (NASDAQ:PRTC) outlined progress across its portfolio in its 2026 half-year results call, highlighting external financings for Celea Therapeutics and Seaport Therapeutics, regulatory progress at Gallop Oncology, and a strategy centered on earlier external funding for its founded entit
Charlie Nunn, chief executive of Lloyds Banking Group (NYSE:LYG), said U.K. households and businesses have remained resilient despite a slower-growth economic backdrop, while outlining the bank’s strategy for growth, investment and efficiency through 2030.
Speaking at a Bank of America event, Nunn
Kingfisher (LON:KGF) reported higher first-half profit and upgraded its full-year outlook, citing gross-margin gains, cost discipline and continued growth in trade, e-commerce and marketplace operations despite mixed conditions across its home-improvement markets.
Adjusted pre-tax profit rose 9.9%
Luceco (LON:LUCE) reported higher first-half revenue and profit, led by rapid growth in energy-transition products, and said it now expects full-year adjusted operating profit to exceed market expectations.
Revenue rose 13.4% to £142.6 million in the first half, while adjusted operating profit incr
Henry Boot (LON:BOOT) reported a weaker first-half performance amid subdued transaction activity across its markets, with revenue falling 19% to just under £81 million and the group posting an operating loss of £3.9 million.
Chief Financial Officer Darren Littlewood said the result was below expect
Target Healthcare REIT (LON:THRL) reported higher earnings, net asset value and dividend cover for the year ended June 30, 2026, as inflation-linked rent increases, asset-management activity and lower borrowing levels supported results.
Chief Executive Kenneth MacKenzie said the company delivered a
Teva Pharmaceutical Industries (NYSE:TEVA) Chief Executive Officer Richard Francis said the company has shifted from being viewed primarily as a generics manufacturer toward a biopharmaceutical company with a growing innovative medicines portfolio, while maintaining and expanding its generics operat
Smiths Group (LON:SMIN) reported organic revenue growth and margin expansion for fiscal 2026 while completing a major portfolio reshaping that left the company focused on its John Crane and Flex-Tek businesses.
The company said it completed the sales of Smiths Interconnect and Smiths Detection, rea
Abeona Therapeutics (NASDAQ:ABEO) executives outlined the early commercial rollout of ZEVASKYN, an autologous cell sheet-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), during the Morgan Stanley Global Healthcare Conference. Management emphasized that the launch requires a
National Bank of Canada (TSE:NA) sees commercial banking as a major growth lever following its acquisition of Canadian Western Bank, with management pointing to integration progress, expanding product capabilities and opportunities in business succession planning across Canada.
Judith Ménard, Head
Compass Pathways (NASDAQ:CMPS) said it expects to complete its rolling New Drug Application submission for its synthetic psilocybin treatment, COMP360, in the fourth quarter and continues to target a potential commercial launch for treatment-resistant depression in the first half of 2027.
Speaking
Canadian Pacific Kansas City (NYSE:CP) President and CEO Keith Creel said the railroad remains positioned to meet its full-year growth and earnings outlook despite a challenging freight environment, trade uncertainty and commodity-specific headwinds.
Speaking at the 14th Annual Laguna Conference, C
Aramark (NYSE:ARMK) executives said the company’s growth-focused operating model, higher client retention and expansion into data-center workforce hospitality are supporting an outlook for continued revenue growth and margin improvement.
Speaking at the Goldman Sachs Global Consumer and Retail Conf
Verastem (NASDAQ:VSTM) executives outlined the company’s commercial and clinical priorities at an H.C. Wainwright event, highlighting the launch of its AVMAPKI FAKZYNJA CO-PACK for KRAS-mutated low-grade serous ovarian cancer and the advancement of its KRAS G12D inhibitor, VS-7375, across pancreatic
Nasdaq (NASDAQ:NDAQ) CFO Sarah Youngwood said the company sees a constructive macroeconomic backdrop, citing investment in artificial intelligence and digital technologies, resilient consumers and corporate earnings that she said are supporting market valuations.
Speaking at a fireside chat with an
Grab (NASDAQ:GRAB) said it has agreed to acquire a controlling 60% equity interest in consumer finance platform Atome Financial, a transaction the Southeast Asian technology company said would accelerate the scale and profitability of its financial-services segment.
Chief Executive Officer Anthony
Tempus AI (NASDAQ:TEM) Founder and CEO Eric Lefkofsky said the company’s second-quarter performance was supported by continued demand for comprehensive genomic profiling and growth in its data-licensing business.
Speaking at Morgan Stanley’s Global Healthcare Conference, Lefkofsky said the diagnost
Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services capabilities and momentum in its international businesses.
Speaking at the Morgan Stanley Global Heal
Five Below (NASDAQ:FIVE) executives said the retailer’s recent performance reflects a customer-focused strategy centered on product assortment, simplified pricing, marketing and store experience improvements, while management sees continued runway for comparable-sales and unit growth.
Chief Executi
Village Farms International (NASDAQ:VFF) told investors at the iAccess Alpha Virtual Best Ideas Fall Investment Conference that it is positioned for further growth in international cannabis markets, supported by greenhouse capacity, EU GMP certification and a net-cash balance sheet.
Sam Gibbons, se
ResMed (NYSE:RMD) outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing demand generation, patient adherence and ongoing product innovation in sleep and respiratory care.
Chairman and Chief Executive Officer Mick Farrell sai
Novo Nordisk A/S (NYSE:NVO) outlined an updated strategy at its Capital Markets Day centered on diabetes and obesity, expansion into blood and endocrine disorders, liver disease and cardiovascular conditions, and a growing focus on consumer-facing prescription medicine channels.
The company said it
Bloom Energy's fuel-cell backlog, hyperscaler approvals, and Brookfield financing deal are fueling AI power demand, even as analysts raise targets and scandium supply questions persist.
Tapestry stock has fallen over 30% from its summer high despite strong FY2026 results, a raised dividend, and new buybacks, with analysts still rating shares Moderate Buy.
DICK'S Sporting Goods (NYSE:DKS) executives said the athletic footwear market remains healthy despite pressure on certain legacy sneaker styles and increased promotional activity, arguing that consumer demand remains strong for innovative products and a broader set of brands.
During a fireside chat
Insiders and institutions are buying DICK's Sporting Goods shares after a post-earnings sell-off, as analysts see upside from Foot Locker integration despite a mostly Hold rating consensus.
Salesforce's expanded OpenAI partnership highlights AI's impact on SaaS, boosting interest in software ETFs IGV and WCLD, which have rallied but differ in risk and holdings.
Consumer demand rose 7.9% year-over-year in August even as retail stocks sold off, and TradeSmith's Andy Swan sees Walmart, Home Depot and Amazon benefiting.
Capri (NYSE:CPRI) expects growth to accelerate in the second half of the year as new products, increased marketing investment and store renovations support its Michael Kors and Jimmy Choo brands, executives said at the Goldman Sachs Global Retail and Consumer Conference.
Chairman, CEO and Director
TJX Companies, Burlington Stores and Dick's Sporting Goods have all cratered. Oil-squeezed spending and sub-20 RSI readings frame a long-dated options play.
Red Cat (NASDAQ:RCAT) is positioning its drone and unmanned surface vessel businesses around lessons drawn from active conflict zones, with Chairman and CEO Jeff Thompson emphasizing battlefield testing, production readiness and interoperability as key differentiators.
Speaking at a Piper Sandler e
Oracle, British American Tobacco, Cisco, Charles Schwab, and Goldman Sachs each combine dividend yield, projected earnings growth, and Moderate Buy analyst ratings, per MarketBeat data.
Celestica, Penguin Solutions, and ACM Research have all raised fiscal 2026 guidance yet trade at least 20% below recent highs, offering compressed valuations ahead of upcoming earnings reports.
Quest Diagnostics (NYSE:DGX) CEO and President Jim Davis said the diagnostic testing company is exceeding the growth framework it outlined at its prior investor day, driven largely by organic growth, consumer-health demand and partnerships rather than a heavier-than-expected pace of acquisitions.
D
Fulgent Genetics, Joby Aviation, and Veritone pursue unconventional business models in genomics, eVTOL aircraft, and AI media, backed by notable financial and operational milestones.
DaVita, Franklin Resources, and Archer Daniels Midland have each gained more than 30% year to date in 2026, offering investors diversification away from AI-driven stock market gains.
As the Iran conflict pushes tanker rates past $1 million per day, investors weigh Okeanis Eco Tankers, International Seaways, and the Breakwave Tanker Shipping ETF as ways to trade the shipping surge.
RingCentral (NYSE:RNG) Chief Financial Officer Vaibhav Agarwal said IT spending remains healthy, with artificial intelligence taking a growing share of both existing and incremental technology budgets as customers move beyond experimentation and focus on measurable returns.
Speaking at a Piper Sand
Meta's new Muse AI agent boosted shares and app downloads, but analysts at J.P. Morgan, Mizuho, and Oppenheimer disagree on its adoption and monetization potential.
Microsoft, U.S. Bancorp, and Lamar Advertising all raised their dividends after strong earnings, with Lamar also considering a special dividend on top of its 4.5% yield.
Atlassian, Salesforce, and Dynatrace shares have rebounded sharply in 2026 as AI adoption boosts demand for their products rather than eroding it, per recent earnings data.
Asana (NYSE:ASAN) is preparing to launch its Agentic Work Management platform, a product and packaging shift that Chief Financial Officer Aziz Megji said is intended to combine the company’s collaborative work-management tools with artificial intelligence capabilities and create new consumption-base
Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens.
Chief Executive Offi
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) said it plans to begin registrational studies next year for its lead T-cell engager, gamgertamig, following a broad restructuring of its legacy cell-therapy operations and the acquisition of assets from Ouro Medicines.
Speaking at M
Ardelyx (NASDAQ:ARDX) expects to generate close to $500 million in revenue this year and reach profitability in 2027, supported by continued growth of its IBS-C treatment IBSRELA and hyperphosphatemia treatment XPHOZAH, executives said at a Morgan Stanley event.
Chief Executive Officer Mike Raab sa
Canadian National Railway (NYSE:CNI) CEO Tracy Robinson said the railroad is pursuing growth opportunities in Mexico, energy, agriculture and selected domestic markets while relying on prior infrastructure investments to support volume gains without a major increase in capital spending.
Speaking at
Cognex (NASDAQ:CGNX) Chief Financial Officer Dennis Fehr said the machine-vision company is pursuing growth across logistics, packaging, semiconductors, electronics and data-center supply chains, supported by artificial intelligence-enabled products, an expanded customer base and operating-efficienc
Cybin (NASDAQ:HELP) executives outlined plans for its late-stage depression program, including an expected fourth-quarter Phase 3 data readout for HLP003, during H.C. Wainwright’s 28th Annual Global Investment Conference. The company, referred to in the presentation as Helus Pharma, is developing se
S&P Global (NYSE:SPGI) is seeing continued growth across its Market Intelligence, Ratings, Indices and Energy businesses, supported by commercial integration, artificial intelligence adoption and productivity initiatives, Chief Financial Officer Eric Aboaf said during a Barclays conference discu
Fifth Third Bancorp (NASDAQ:FITB) said it is tracking toward the favorable ends of its third-quarter guidance ranges following the completion of its Comerica conversion over Labor Day weekend, with executives citing stronger deposit growth, stable customer retention and expense savings that are arri
